Lv1
50 积分 2024-08-14 加入
Safety of denosumab in patients with chronic kidney disease
8天前
已关闭
Molecular mechanism of glucocorticoid-induced hyperglycemia
9天前
已关闭
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
15天前
已完结
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
19天前
已完结
Efficacy of denosumab on bisphosphonate-treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids
24天前
已完结
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report
1个月前
已完结
Denosumab Improves Glomerular Filtration Rate in Osteoporotic Patients With Normal Kidney Function by Lowering Serum Phosphorus
1个月前
已完结
Dose-specific effects of denosumab on serum calcium levels in patients with osteoporosis and various renal functions
1个月前
已完结
RANKL/RANK contributes to the pathological process of type 2 diabetes mellitus through TRAF3 activation of NIK
1个月前
已完结
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
1个月前
已完结
皖公网安备34019202002308
